Isabella Guimarães Olmo

Isabella Guimarães Olmo

Auto-generated profile, based on publicly available information

Isabella Guimarães Olmo

Department of Biochemistry and Immunology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2016 in Current Neuropharmacology
Verified
Journal Article
Open access
TFTalita H. Ferreira-Vieira
Talita H. Ferreira-Vieira
IGIsabella M. Guimaraes
Isabella M. Guimaraes
FSFlavia R. Silva
Flavia R. Silva
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro
Acetylcholine (ACh) has a crucial role in the peripheral and central nervous systems. The enzyme choline acetyltransferase (ChAT) is responsible for synthesizing ACh from acetyl-CoA and choline in the cytoplasm and the vesicular acetylcholine transporter (VAChT) uptakes the neurotransmitter into synaptic vesicles. Following depolarization, ACh undergoes exocytosis reaching the synaptic cleft, where it can bind its receptors, including muscarinic and nicotinic receptors. ACh present at the synaptic cleft is promptly hydrolyzed by the enzyme acetylcholinesterase (AChE), forming acetate and choline, which is recycled into the presynaptic nerve terminal by the high-affinity choline transporter (CHT1). Cholinergic neurons located in the basal forebrain, including the neurons that form the nucleus basalis of Meynert, are severely lost in Alzheimer’s disease (AD). AD is the most ordinary cause of dementia affecting 25 million people worldwide. The hallmarks of the disease are the accumulation of neurofibrillary tangles and amyloid plaques. However, there is no real correlation between levels of cortical plaques and AD-related cognitive impairment. Nevertheless, synaptic loss is the principal correlate of disease progression and loss of cholinergic neurons contributes to memory and attention deficits. Thus, drugs that act on the cholinergic system represent a promising option to treat AD patients.

22 October 2018 in Nature Materials
Verified
Journal Article
Closed access
PDF file
JJJoshua A. Jackman
Joshua A. Jackman
VCVivian V. Costa
Vivian V. Costa
SPSoohyun Park
Soohyun Park
ARAna Luiza C. V. Real
Ana Luiza C. V. Real
JPJae Hyeon Park
Jae Hyeon Park
Nam-Joon ChoNam-Joon Cho
Nam-Joon Cho

23 August 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
IOIsabella G. Olmo
Isabella G. Olmo
TCToniana G. Carvalho
Toniana G. Carvalho
VCVivian V. Costa
Vivian V. Costa
JAJuliana Alves-Silva
Juliana Alves-Silva
CFCarolina Zaniboni Ferrari
Carolina Zaniboni Ferrari
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro
Zika virus (ZIKV) has recently caused a worldwide outbreak of infections associated with severe neurological complications, including microcephaly in infants born from infected mothers. ZIKV exhibits high neurotropism and promotes neuroinflammation and neuronal cell death. We have recently demonstrated that N-methyl-D-aspartate receptor (NMDAR) blockade by memantine prevents ZIKV-induced neuronal cell death. Here we show that ZIKV induces apoptosis in a non-cell autonomous manner, triggering cell death of uninfected neurons by releasing cytotoxic factors. Neuronal cultures infected with ZIKV exhibit increased levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and glutamate. Moreover, infected neurons exhibit increased expression of GluN2B and augmented intracellular Ca2+ concentration. Blockade of GluN2B-containing NMDAR by ifenprodil normalizes Ca2+ levels and rescues neuronal cell death. Notably, TNF-α and IL-1β blockade decreases ZIKV-induced Ca2+ flux through GluN2B-containing NMDARs and reduces neuronal cell death, indicating that these cytokines might contribute to NMDAR sensitization and neurotoxicity. In addition, ZIKV infected cultures treated with ifenprodil exhibits increased activation of the neuroprotective pathway including extracellular signal-regulated kinase (ERK) and cAMP response element binding protein (CREB), which may underlie ifenprodil-mediated neuroprotection. Together, our data shed some light on the neurotoxic mechanisms triggered by ZIKV and begin to elucidate how GluN2B-containing NMDAR blockade can prevent neurotoxicity.

3 May 2017 in mBio
Verified
Journal Article
Open access
PDF file
VCVivian V. Costa
Vivian V. Costa
JSJuliana L. Del Sarto
Juliana L. Del Sarto
RRRebeca de Paiva Froes Rocha
Rebeca de Paiva Froes Rocha
FSFlavia R. Silva
Flavia R. Silva
JDJuliana G. Doria
Juliana G. Doria
MTMauro Martins Teixeira
Mauro Martins Teixeira
Zika virus (ZIKV) infection is a global health emergency that causes significant neurodegeneration. Neurodegenerative processes may be exacerbated by N -methyl- d -aspartate receptor (NMDAR)-dependent neuronal excitoxicity. Here, we have exploited the hypothesis that ZIKV-induced neurodegeneration can be rescued by blocking NMDA overstimulation with memantine. Our results show that ZIKV actively replicates in primary neurons and that virus replication is directly associated with massive neuronal cell death. Interestingly, treatment with memantine or other NMDAR blockers, including dizocilpine (MK-801), agmatine sulfate, or ifenprodil, prevents neuronal death without interfering with the ability of ZIKV to replicate in these cells. Moreover, in vivo experiments demonstrate that therapeutic memantine treatment prevents the increase of intraocular pressure (IOP) induced by infection and massively reduces neurodegeneration and microgliosis in the brain of infected mice. Our results indicate that the blockade of NMDARs by memantine provides potent neuroprotective effects against ZIKV-induced neuronal damage, suggesting it could be a viable treatment for patients at risk for ZIKV infection-induced neurodegeneration. IMPORTANCE Zika virus (ZIKV) infection is a global health emergency associated with serious neurological complications, including microcephaly and Guillain-Barré syndrome. Infection of experimental animals with ZIKV causes significant neuronal damage and microgliosis. Treatment with drugs that block NMDARs prevented neuronal damage both in vitro and in vivo . These results suggest that overactivation of NMDARs contributes significantly to the neuronal damage induced by ZIKV infection, and this is amenable to inhibition by drug treatment.

1 January 2015 in Neurobiology of Disease
Verified
Journal Article
Closed access
JDJ.G. Doria
J.G. Doria
JSJ.M. de Souza
J.M. de Souza
JAJ.N. Andrade
J.N. Andrade
HRH.A. Rodrigues
H.A. Rodrigues
IGI.M. Guimaraes
I.M. Guimaraes
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro

10 April 2015 in Molecular Brain
Verified
Journal Article
Open access
PDF file
IGIsabella M Guimaraes
Isabella M Guimaraes
TCToniana G Carvalho
Toniana G Carvalho
SFStephen Sg Ferguson
Stephen Sg Ferguson
GPGrace S Pereira
Grace S Pereira
Fabiola M. RibeiroFabiola M. Ribeiro
Fabiola M. Ribeiro
The metabotropic glutamate receptor 5 (mGluR5) is involved in various brain functions, including memory, cognition and motor behavior. Regarding locomotor activity, we and others have demonstrated that pharmacological antagonism of mGluR5 promotes hyperkinesia in mice. Moreover, increased locomotor activity can also be observed in mice following the genetic deletion of mGluR5. However, it is still unclear which specific brain substrates contribute to mGluR5-mediated regulation of motor function. Thus, to better understand the role of mGluR5 in motor control and to determine which neural substrates are involved in this regulation we performed stereotactic microinfusions of the mGluR5 antagonist, MPEP, into specific brain regions and submitted mice to the open field and rotarod apparatus. Our findings indicate that mGluR5 blockage elicits distinct outcomes in terms of locomotor activity and motor coordination depending on the brain region injected with mGluR5 antagonist. MPEP injection into either the dorsal striatum or dorsal hippocampus resulted in increased locomotor activity, whereas MPEP injection into either the ventral striatum or motor cortex resulted in hypokinesia. Moreover, MPEP injected into the olfactory bulb increased the distance mice traveled in the center of the open field arena. With respect to motor coordination on the rotarod, injection of MPEP into the motor cortex and olfactory bulb elicited decreased latency to fall. Taken together, our data suggest that not only primarily motor neural substrates, but also limbic and sensory structures are involved in mGluR5-mediated motor behavior.